Company news

ClearPoint Neuro Inc. news in 2022

ClearPoint Neuro Inc.'s news releases, calls and decks from 2022, newest first.

View company

ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden

December 11, 2022

ClearPoint Neuro to Present at Upcoming Investor Conferences

November 8, 2022

ClearPoint Neuro Reports Third Quarter 2022 Results

November 7, 2022

ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022

October 25, 2022

ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System

September 21, 2022

ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer

September 19, 2022

ClearPoint Neuro Announces FDA Clearance for Software Version 2.1

September 18, 2022

ClearPoint Neuro Reports Second Quarter 2022 Results

August 8, 2022

ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model

August 8, 2022

ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs

August 7, 2022

ClearPoint Neuro to Announce Second Quarter 2022 Results August 9, 2022

July 25, 2022

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency

July 20, 2022

ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy

June 28, 2022

ClearPoint Neuro Announces Receipt of MDSAP Certification

June 1, 2022

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency

May 19, 2022

ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC

May 12, 2022

ClearPoint Neuro Reports First Quarter 2022 Results

May 10, 2022

ClearPoint Neuro and Higgs Boson Health Announce Collaboration

May 2, 2022

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1

April 27, 2022

ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power Expansion of the ClearPoint Platform into the Operating Room

April 26, 2022

ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022

April 25, 2022

ClearPoint Neuro to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Mini Conference

March 28, 2022

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2021 Results

February 28, 2022

ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results and Guidance for Full Year 2022 Revenue

February 14, 2022

ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual Conference

January 4, 2022

Calls in 2022

Decks in 2022